|
Feng Jifeng is a Chinese oncologist at Jiangsu Cancer Hospital and Nanjing Medical University, both located in Nanjing, China.〔(【引用サイトリンク】title=Brief introduction for editors: Prof. Feng Jifeng )〕 He specializes in the diagnosis and treatment of malignant tumors such as lung cancer, breast cancer, and lymphoma. He has a special interest in aspects of biotherapy and the correlation between dosage of chemotherapeutics and their curative effect and toxicity. He currently holds the following positions: *Director of national pharmaceutical clinical trial institute in Jiangsu Cancer Hospital *Chief physician of Jiangsu Cancer Hospital *Director of Quality Control Centre of Jiangsu Medical Oncology and Chinese Medical Association *Vice director of Chinese Society of Clinical Cancer Chemotherapy of Chinese Anti-Cancer Association *Editor-in-chief of the ''Journal of International Translational Medicine'' ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Feng Jifeng」の詳細全文を読む スポンサード リンク
|